Detection and Characterization of Tumor Changes in 18F-FDG PET Patient Monitoring Using Parametric Imaging
暂无分享,去创建一个
Irène Buvat | Patrick Emonts | Hatem Necib | Bruno Vanderlinden | Antoine Wagner | Patrick Flamen | Camilo Garcia | I. Buvat | P. Flamen | B. Vanderlinden | Camilo Garcia | Alain Hendlisz | A. Hendlisz | P. Emonts | H. Necib | A. Wagner | C. Garcia
[1] H. Malcolm Hudson,et al. Accelerated image reconstruction using ordered subsets of projection data , 1994, IEEE Trans. Medical Imaging.
[2] Eileen O. Smith,et al. Difference images calculated from ictal and interictal technetium-99m-HMPAO SPECT scans of epilepsy. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] Gérard Govaert,et al. Gaussian parsimonious clustering models , 1995, Pattern Recognit..
[4] M. Sasaki,et al. A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma , 1996, Annals of nuclear medicine.
[5] K. Herholz,et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. , 1999, European journal of cancer.
[6] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[7] M Van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.
[8] David J. Hawkes,et al. Voxel Similarity Measures for 3D Serial MR Brain Image Registration , 2000, IEEE Trans. Medical Imaging.
[9] Sébastien Ourselin,et al. Block Matching: A General Framework to Improve Robustness of Rigid Registration of Medical Images , 2000, MICCAI.
[10] A. Fischman,et al. Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. , 2002, International journal of radiation oncology, biology, physics.
[11] Danny Rischin,et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] R. Boellaard,et al. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] M. Schwaiger,et al. Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[14] Wolfgang A Weber,et al. Use of PET for monitoring cancer therapy and for predicting outcome. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] Gérard Govaert,et al. Model-based cluster and discriminant analysis with the MIXMOD software , 2006, Comput. Stat. Data Anal..
[16] R. Wahl,et al. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.
[17] S. Ben-Haim,et al. 18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response* , 2008, Journal of Nuclear Medicine.
[18] P. Flamen,et al. Is positron emission tomography (PET) with FDG an early predictor of the RECIST morphological response to chemotherapy in metastatic colorectal cancer patients (mCRC)? , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.